| ★ | What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD | | 142 | Estados Unidos | |
| 6 | GP-SOD Plus Targeted Phototherapy Improves Vitiligo Repigmentation | | 249 | Estados Unidos | 60 |
| 3 | Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD | | 198 | Estados Unidos | 61 |
| 2 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 65 |
| 14 | COMP360 Psilocybin's 26-Week Data in Treatment-Resistant Depression I Boadie Dunlop, MD | | 178 | Estados Unidos | 58 |
| 20 | SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo | | 174 | Estados Unidos | 58 |
| 18 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 58 |
| 1 | AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD | | 129 | Estados Unidos | 76 |
| 10 | FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD | | 123 | Estados Unidos | 59 |
| 17 | Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk | | 120 | Estados Unidos | 58 |
| 4 | Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease | ATS 2026 With Gerard Criner, MD | | 113 | Estados Unidos | 61 |
| 19 | AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD | | 105 | Estados Unidos | 58 |
| 8 | Brensocatib, 1 Year Later: Who Benefits Most? | Mark Metersky, MD | | 98 | Estados Unidos | 59 |
| 11 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 59 |
| 12 | What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata | | 82 | Estados Unidos | 59 |
| 9 | How to Sequence Omalizumab, Dupilumab, and Remibrutinib in CSU | | 74 | Estados Unidos | 59 |
| 15 | Avapritinib's 4-Year Impact on Quality of Life in ISM | Thanai Pongdee, MD | | 73 | Estados Unidos | 58 |
| 13 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 58 |
| 16 | Addressing Advances and Roadblocks in Lipid Management, With Joseph Saseen, PharmD | | 64 | Estados Unidos | 58 |
| 7 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 60 |
| 5 | Mitraa-T1D: AI-Driven Converastional Tool Improves T1D Diabetes Distress, Self-Care Behaviors | | 9 | Estados Unidos | 61 |